Table 2 Baseline migraine characteristics by head pain outcome group at 2 h post-dose
Baseline migraine characteristic | Pain freedom (N = 913) | Improved to mild pain (N = 864) | Continued moderate/severe pain (N = 1052) |
|---|---|---|---|
Time to dosing hours, mean (SD) | 1.0 (1.7) | 1.29 (1.69) | 1.25 (1.56) |
Pain severity, n (%) | |||
Severe | 230 (25.2) | 170 (19.7) | 390 (37.1) |
Moderate | 683 (74.8) | 694 (80.3) | 662 (62.9) |
Migraine-associated symptoms, n (%) | |||
Photophobia | 726 (79.5) | 713 (82.5) | 903 (85.8) |
Phonophobia | 600 (65.7) | 576 (66.7) | 740 (70.3) |
Nausea | 384 (42.1) | 395 (45.7) | 556 (52.9) |
Migraine-related functional disabilitya, n (%) | |||
Need complete bed rest | 131 (14.3) | 112 (13.0) | 245 (23.3) |
Marked interference | 489 (53.6) | 521 (60.3) | 612 (58.2) |
Mild interference | 293 (32.1) | 231 (26.7) | 195 (18.5) |